2018 FDA Tides Harvest
In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and econ...
Main Authors: | Danah Al Shaer, Othman Al Musaimi, Fernando Albericio, Beatriz G. de la Torre |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/12/2/52 |
Similar Items
-
A comparative analysis of international health technology assessments for novel gene silencing therapies: patisiran and inotersen
by: Sergio Iannazzo
Published: (2021-03-01) -
2019 FDA TIDES (Peptides and Oligonucleotides) Harvest
by: Danah Al Shaer, et al.
Published: (2020-03-01) -
2020 FDA TIDES (Peptides and Oligonucleotides) Harvest
by: Othman Al Musaimi, et al.
Published: (2021-02-01) -
Advances in the treatment of hereditary transthyretin amyloidosis: A review
by: Morie A. Gertz, et al.
Published: (2019-09-01) -
Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma
by: Sriram Gubbi, et al.
Published: (2021-01-01)